NCT05938647 - Severe Dengue in Critical Care at Villavicencio, Colombia. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions

Severe Dengue

Interventions

OTHER

Risk factor: group 3

Severe dengue, no shock. No diagnostic or therapeutic intervention; the characteristics of participants will be analyzed by demographics, severity, laboratory results, fluids accumulation, and outcomes.

OTHER

Risk factor: group 4

Dengue shock syndrome. No diagnostic or therapeutic intervention; the characteristics of participants will be analyzed by demographics, severity, laboratory results, fluids accumulation, and outcomes

Trial Locations (2)

50001

RECRUITING

Clinica Primavera, Villavicencio

RECRUITING

Hospital Departamental de Villavicencio, Villavicencio

All Listed Sponsors

collaborator

Cooperative University of Colombia

OTHER

lead

Hospital Departamental de Villavicencio

OTHER